RxDoctor Payments Data

Evelyn Javier

Family · Perth Amboy, NJNPI 1184143398

Payments from drug & device makers

$2,406in general payments, 2019–2025

Across 84 payments — averaging $28.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$570
  • AstraZeneca$423
  • Boehringer Ingelheim$196
  • Insulet Corporation$178
  • Amgen$161
  • Phathom Pharmaceuticals, Inc.$121
  • plus $756 from 18 others

What the payments were for

  • Food & beverage$2,406100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,406 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide30$40,290
JardianceEmpagliflozin47$36,820
JanuviaSitagliptin Phosphate47$36,218
FarxigaDapagliflozin Propanediol40$26,794
JanumetSitagliptin Phos/Metformin Hcl29$17,666
VascepaIcosapent Ethyl26$10,485
Omega-3 Acid Ethyl Esters33$2,694
Diclofenac Sodium65$1,974
Ibandronate Sodium30$1,618
Alcohol Prep PadsAlcohol Antiseptic Pads44$1,597
Atorvastatin Calcium167$1,510
Rosuvastatin Calcium119$1,488
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro11$1,474
Naproxen14$1,203
Humulin 70-30Insulin Nph Hum/Reg Insulin Hm15$1,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$13$53,88476 claims
Novo NordiskOzempic$570$40,29030 claims
Boehringer IngelheimJardiance$196$36,82047 claims
AstraZenecaFarxiga$423$26,79440 claims
Lilly USA, LLCHumulin 70-30$81$1,19615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,692 family providers in New Jersey.

Other family in Perth Amboy

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →